1.Application and advantages of TCM in treating breast cancer
China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(07):-
Disdvantages of chemotherapy in treating breast cancer were insensitivity or intolerance.There were different opinions on chemotherapy in treating negative axillary lymph notes or positive hormone receptors after breast cancer surgery.The advantages of TCM in treating breast cancer were:there were many Chinese medical oncologists who had rich clinical experiences in treating breast cancer before and during surgery,before and during chemotherapy,before and during radiotherapy and during the consolidation period;treatment according to syndrome differentiation with TCM for different stages of breast cancer had been gradually standardized;a well developed network of academic information provided a good platform for establishing the unified treatment protocols with TCM for different stages of breast cancer.It was indicated that large scale prospective clinical trials with TCM in the treatment of after-surgery breast cancer patients who had negative auxillary lymph notes and positive hormone receptors should be carried out.
2.Analysis of Factors on Quality of Life in Patients with Breast Cancer After Surgery and Therapeutic Effect of Chinese Herbal Medicine
Honglin SITU ; Huayu ZHU ; Qianjun CHEN ; Yi UN
Journal of Guangzhou University of Traditional Chinese Medicine 1999;0(02):-
1 was found in grouping, abortion times and metastasis in axillary lymph nodes, and OR
3.Effects of Runing Recipe II on expressions of p53 and ras oncogene proteins and cell cycle of the transplanted Ca761 breast cancer in mice
Qianjun CHEN ; Yian WANG ; Honglin SITU ; Demin LU ; Liping REN ; Xiwen LAI ; Pengxi LIU ; Yi LIN
Journal of Integrative Medicine 2005;3(3):225-8
OBJECTIVE: To explore the mechanisms of Runing Recipe II (a recipe composed of traditional Chinese herbs) in inhibiting the growth of breast cancer by observing its effects on the expressions of p53 and ras oncogene proteins and cell cycle of the transplanted Ca761 breast cancer in mice. METHODS: We established the breast cancer model by transplanting Ca761 cells in mice. The mice were randomly divided into 4 groups: normal saline control group, CTX-treated group, Runing Recipe II-treated group, and Runing Recipe II and CTX-treated group, with 12 mice in each group. We detected the cell cycle of the cancer cells in the mice's transplanted tumor with flow cytometry and measured the expressions of p53 and ras oncogene proteins in the transplanted tumor with immunohistochemical methods. RESULTS: The percentages of tumor cells in S-phase of the Runing Recipe II treated group, CTX-treated group and Runing Recipe II and CTX-treated group were significantly lower than that of the normal saline control group respectively (P<0.05). The percentage of tumor cells in G(0)-G(1) phase of the Runing Recipe II treated group was lower than that of the CTX-treated group (P<0.05), while the percentage of tumor cells in G(2)-M phase was higher than that of the CTX-treated group. The immunoreactive scores (IRSs) of p53 in the Runing Recipe II treated group and Runing Recipe II and CTX-treated group were significantly lower than that in the normal saline control group respectively (P<0.05). The effect of CTX on the expression of p53 was not significant. The IRSs of ras oncogene protein in the Recipe II-treated group, CTX-treated group and Runing Recipe II and CTX-treated group were lower than that in the normal saline control group respectively (P<0.05). CONCLUSION: Runing Recipe II can inhibit the growth of Ca761 breast cancer in mice by controlling the cell cycle of the transplanted tumor. This may be related to its effect on the gene expressions of p53 and ras in the tumor tissue.
4.Experience of LIN Yi in Disease-Syndrome-Syptom Differentiation and Treatment of Breast Cancer in Consolidation Phase
Xinyue ZHAO ; Guibin WANG ; HongLin SITU ;
Journal of Traditional Chinese Medicine 2024;65(1):26-30
This article summarized the clinical experience of Professor LIN Yi in applying the idea of disease-syndrome-syptom combination to the differentiation and treatment of breast cancer in consolidation phase. It is believed that the fundamental pathogenesis of breast cancer in consolidation phase is deficiency of healthy qi, so the treatment should emphasize on reinforcing healthy qi as the main and eliminating pathogen as the supplement. Commonly, Sijunzi Decoction (四君子汤), Shenling Baizhu Powder (参苓白术散), and Liuwei Dihuang Decoction (六味地黄汤) are used as the basic formula to strengthen the spleen and kidney to reinforce healthy qi, and Baihua Sheshe Cao (Scleromitrion diffusum [Willd.] R.J.Wang), Yiyiren (Coix lacryma-jobi L.), and ezhu (Curcuma aromatica Salisb.) are used to eliminate cancer toxin. It is also believed that the biological characteristics of different molecular subtypes of breast cancer are of great significance to the syndrome differentiation and treatment in traditional Chinese medicine, therefore, the formulas used in clinical practice are often selected taking into considerations of molecular subtypes of breast cancer. For those with positive sex hormone receptor, the most important thing is to replenish the congenital and benefit kidney essence, with modified Baihua Qiqi Decoction (白花芪杞汤); for those with negative sex hormone receptor, the first step is to strengthen spleen and replenish kidneys, and it is especially important to strengthen the spleen with Baihua Qiling Decoction (白花芪苓汤). At the same time, it is suggested that the primary and the secondary symptoms of patients should be differentiated, and the diseases and symptoms, as well as the modern medical laboratory indicators should be combined to give suitable medication.